GPACTS 2026 Hyderabad Summit Overview

The Global Pharma AI, Compliance & Technology Summit (GPACTS) will convene its flagship edition on 3 September 2026 at the Novotel Hyderabad Convention Centre (HICC) in Hyderabad, Telangana. The summit is expected to attract 350‑400 senior decision‑makers from pharmaceutical technology, manufacturing, quality, compliance, data and cybersecurity functions.

Key Participants and Leadership

The event is powered by Honeywell, underscoring its role as the primary technology partner. Additional confirmed partners include Rockwell Automation, Nividous Software, Thermo Fisher Scientific, Incep Bio, Abhiyanta Tech, and Ample Logic. A startup showcase will feature NM Technokrafts, Wizmoid, and AI4Pharma, bringing emerging solutions into dialogue with senior pharma executives.

The chief guest will be A.V.P.S. Chakravarty, Chairman of the Federation of Pharma Entrepreneurs (FOPE). He will be joined by Dr. Sridhar Reddy, Honorary Secretary of the Indian Pharmaceutical Association (IPA), and Sarvesh Singh, CEO of Telangana Life Sciences, providing regulatory, industry‑association and state perspectives.

Prominent speakers confirmed are:

  • Dr. Ajaz Hussain, former FDA Director
  • Ramanarayana Parhi, Vice President and CIO, Alkem Laboratories
  • Rajesh T, Digital Transformation Head, Dr. Reddy’s Laboratories
  • Dr. Deepa Pangaonkar, Vice President – Quality IT, Wockhardt
  • Karthick Raja, CIO, Granules India
  • Praveen Kumar Baheti, Vice President – IT, Biological E.

The summit’s organizer, Shipra Singh, Founder and Director of GPACTS, emphasized that the agenda will address responsible AI and governance in validated environments, evolving data‑protection requirements, manufacturing cybersecurity, digital batch processes, manufacturing execution systems, laboratory software, connected quality systems and digital twins.

Programme Focus

The Hyderabad edition will concentrate on how the pharmaceutical sector can scale digital transformation—including AI, connected manufacturing and data‑led operations—without compromising the stringent controls required in regulated manufacturing. Sessions will be practitioner‑led, featuring cross‑functional discussions and a focus on implementation‑oriented formats.

Historical Context

Earlier in the year, GPACTS held editions in Mumbai and Ahmedabad. Across those two events, 228 delegates and 32 speakers participated, with over 80 % representing pharma end‑user organisations. 40‑50 % of participants held C‑suite or senior leadership roles. The Ahmedabad edition introduced a live ransomware tabletop simulation based on a pharmaceutical manufacturing environment, illustrating the summit’s emphasis on practical risk‑management exercises.

Outlook

Ravindra Warang, Director of GPACTS, noted that feedback from the Mumbai and Ahmedabad gatherings confirmed a strong demand among pharma leaders for implementation insight, peer experience and candid risk discussion. The Hyderabad summit aims to expand this model to a flagship scale, integrating AI, compliance, cybersecurity and manufacturing systems into a single decision‑making forum.

For programme details and registration, interested parties can visit www.gpacts.com.

---